Introduction:

Obstructive sleep apnea (OSA) is a disease where the soft tissues in the throat, including the tongue, collapse and are sucked against the back of the throat. This blocks the upper airway and air flow stops or decrease. When the oxygen level in the brain becomes low enough, the sleeper is partially awaken. The obstruction in the throat clears and the flow of air starts again, usually with a gasp. Most people are not aware this is occurring. Its main aspects are: systemic hypertension, cardiovascular disease and stroke.

Factors that have an effect on Obstructive Sleep Apnea are age, sex, genes, menopause, body weight (strongest risk factor) and, with less importance, alcohol intake and smoking. Based on research studies in Germany the daytime sleepiness is approximately 3-7 % for adult men and 2-5% for adult women.

Apnea is defined as the complete cessation of air flow of at least 10 seconds and is divided into two, obstructive and central.

Hypopnea is defined as the reduction in air flow that is followed by an arousal from sleep or a decrease in oxyhemoglobin saturation.

We will study in this essay the hormonal aspects of OSA and see how hormones can affect or be affected by OSA

Hormones of hypothalamic-pituitary-gonadal axis

Testosterone:

General information:

Relation between Level of testosterone and Obstructive sleep apnea

Physiological aspects associated with low level of testosterone

Mechanism decreasing testosterone level

GROWTH HORMONE

GH levels and obstructive sleep apnea relations:

GH levels and replacement therapy:

Effect of decreased GH level:

PROGESTERONE AND ESTROGEN

CORTISOL

Other hormones

Leptin and Ghrelin hormones and OSA

General introduction

Relation of those hormones with OSA

Continuous Positive Airway Pressure (CPAP) Treatment

Effects of insulin on obstructive sleep apnea

General information:

Relation between insulin and Obstructive Sleep apnea:

How to treat Obstructive sleep apnea associated with insulin resistance:

Conclusion

conclusion figure.pdf


  1. Barrett-Connor and Al. The association of testosterone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. Journal of Clinical Endocrinology and Metabolism. 93(7): 2602–2609. 2008 (1)

  2. Sandblom R E et al. Obstructive sleep apnea syndrome induced by testosterone administration. New england journal of medicine. 308:508-510. 1983. (2)

    • Drimel MolinaF. et Al. Evaluation of testosterone serum levels in patients with obstructive sleep apnea syndrome. Brazilian Journal of Otorhinolaryngology 77 (1) January/February 2011
    (3)
  3. Kirbas G. et al. Obstructive sleep apnea, cigarette, smoking and serum testosterone levels in a male sleep clinic cohort. The Journal of International Medical Research 35: 38 – 45. 2007 (4)

  4. Fabio et al. Neuroendocrine Alterations in Obese Patients with Sleep Apnea Syndrome.International Journal of Endocrinology. Article ID 474518, 2010 (5)

  5. Pekeret Y. al. Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy. Clinical Endocrinology. 65, 98–105 . 2006 (6)

  6. Mahssa Karimi et al. Increased Neck Soft Tissue Mass and Worsening of Obstructive Sleep Apnea after Growth Hormone Treatment in Men with Abdominal Obesity. Journal of clinical sleep medicine Vol.6, No. 3, 2010 (7)

  7. GIANOTTI L. et al. Concomitant Impairment of Growth Hormone Secretion and Peripheral Sensitivity in Obese Patients with Obstructive Sleep Apnea Syndrome. The Journal of Clinical Endocrinology & Metabolism 87(11):p5052–p5057. 2002 (8)

  8. Fotis Kapsimalis. Et al. Obstructive sleep apnea in pregnancy. Sleep Med Clin 2. 603–613. 2007. (9)

  9. Eichling P-S. et al. Menopause related sleep disorders. Journal of Clinical Sleep Medicine, Vol. 1, No. 3, 2005 (10)